J&J raises guidance for 2026 on strong start to the year
Johnson & Johnson said its pharmaceutical sales rose 11.2% in the first quarter of 2026.…
Johnson & Johnson said its pharmaceutical sales rose 11.2% in the first quarter of 2026.…
Lucid Group Inc. named a new chief executive officer and announced $750 million of fresh investment from its…
Shake-up spurred on by rise of AI and threat of major upheaval across the industry…
Republicans are trying to defend a razor-thin majority in the House and are running on tax policies passed…
Hype around Elon Musk, a major moon mission and space-based data centers is driving interest in the sector.…
JPMorgan Chase pulled in $11.6 billion in trading revenue in the first quarter, up 20% from a year…
Global investors grappling with the fallout from the Iran war have slashed their expectations for economic growth by…
The world’s biggest asset manager beat earnings forecasts after a surge into its exchange-traded funds…
Citigroup and BlackRock Investment Institute have both turned bullish on U.S. stocks. They say tech dominance is a…
Somalian lawmakers failed to elect a new president as the parliament’s current term came to an end on…